EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Pyrazolopyrimidine Scaffold: Synthetic Strategies and Biological Applications (2019‐Present)

Anshul Bansal iD, Virender Kumar iD, Ranjana Aggarwal iD, Mona Hooda iD, Suresh Kumar iD, Meera

Archiv der Pharmazie · 2026-03 · 359 (3)

DOI: 10.1002/ardp.70226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, online erschienen am 19.03.2026. Verfasst von Anshul Bansal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, S. A. Jain College, Ambala City, Haryana, India. Hauptthemen laut MEDLINE: Pyrazoles, Pyrimidines, Antineoplastic Agents. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pyrazolopyrimidines are a significant category of heterocyclic fused compounds that have gained growing interest owing to their wide range of biological functions as well as their synthetic all‐purpose. The review draws attention to the current advances (2019–2025) in the synthesis, structural rearrangement, and pharmacological assessments of pyrazolopyrimidines with particular focus on pyrazolo[3,4‐ d ]pyrimidine and pyrazolo[1,5‐ a ]pyrimidine derivatives. The latter scaffolds have also been efficiently and sustainably approached through recent synthetic methodologies, such as multicomponent reactions, microwave‐assisted synthesis, and green chemistry methodologies. Several derivatives have been shown to have strong anticancer, antimicrobial, anti‐inflammatory, and antiviral effects, usually through the action on important enzymes, including CDK2, FLT3, VEGFR‐2, PIM‐1, and Topoisomerase IIa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesPyrimidinesAntineoplastic AgentsHumansAnimalsStructure-Activity RelationshipMolecular StructureAnti-Infective AgentsAnti-Inflammatory AgentsAntiviral Agents

Stichwörter der Autor:innen

antibacterialanticancermolecular dockingpyrazolopyrimidinessynthesis

Substanzen

PyrazolesPyrimidinesAntineoplastic AgentsAnti-Infective AgentsAnti-Inflammatory Agentspyrazolo(1,5-a)pyrimidinepyrazolo(3,4-d)pyrimidineAntiviral Agents

Autor:innen und Institutionen

  • Department of Chemistry, S. A. Jain College, Ambala City, Haryana, India.
  • Department of Chemistry, Khalsa Tri-Centenary, Government College, Ratia, Haryana, India.
  • Council of Scientific and Industrial Research (CSIR) HQ, Vigyan Suchna Bhawan, New Delhi, India.
  • Department of Chemistry, Gurugram University, Gurugram, Haryana, India.
  • Department of Chemistry, S.U.S, Government College, Matak Majri, Karnal, Haryana, India.
  • Department of Chemistry, G. G. J, Government College, Hisar, Haryana, India.

ORCID-Profile: Anshul Bansal, Virender Kumar, Ranjana Aggarwal, Mona Hooda, Suresh Kumar

Zitieren

APA

Bansal, A., Kumar, V., Aggarwal, R., Hooda, M., Kumar, S., & Meera (2026). Advances in Pyrazolopyrimidine Scaffold: Synthetic Strategies and Biological Applications (2019‐Present). Archiv der Pharmazie, 359(3). https://doi.org/10.1002/ardp.70226

Vancouver

Bansal A, Kumar V, Aggarwal R, Hooda M, Kumar S, Meera. Advances in Pyrazolopyrimidine Scaffold: Synthetic Strategies and Biological Applications (2019‐Present). Archiv der Pharmazie. 2026;359(3). doi:10.1002/ardp.70226

BibTeX
@article{Bansal2026,
  author = {Bansal, Anshul and Kumar, Virender and Aggarwal, Ranjana and Hooda, Mona and Kumar, Suresh and Meera},
  title = {Advances in Pyrazolopyrimidine Scaffold: Synthetic Strategies and Biological Applications (2019‐Present)},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {3},
  doi = {10.1002/ardp.70226}
}
Kostenlos starten →